Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2022

View Archived Issues

Novel TIMP3 gene variants tied to early-onset retinopathy

TET2 and KDM6B cooperation tied to chronic myelomonocytic leukemia

AstraZeneca, Mitsubishi Tanabe Pharma present new relaxin receptor 1 agonists

Shanghai Caerulum Pharma Discovery, Azulceu Medicine, Xpiscoric patent abiraterone prodrugs

New coagulation factor XIa inhibitors discovered at Shanghai Leadingtac Pharmaceutical

WDR5/MLL1 interaction inhibitors identified at Etern Biopharma

Hangzhou Purplecrystal Pharma, Hangzhou Innogate Pharma describe GLS1 inhibitors

CXCL8 identified as prognostic biomarker in esophageal squamous cell carcinoma

PARP1 modulates CRC metastasis through Rho GTPase pathway

Balixafortide shows synergy with docetaxel in metastatic prostate cancer preclinical model

DAP3 and DELE1 impact chemosensitization of CRC cells

Lamivudine has beneficial effects in mouse model of Down syndrome

BRCA1 methylation, mutation portend different response to chemotherapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...